Portal de Periódicos da CAPES

Post–COVID-19 Cholangiopathy: A Novel Entity

2021; Lippincott Williams & Wilkins; Volume: 116; Issue: 5 Linguagem: Inglês

10.14309/ajg.0000000000001154

1572-0241

Nitzan Roth, Angela Kim, Taisia Vitkovski, Jianxiang Xia, Guillermo Ramírez, David Bernstein, James M. Crawford,

Liver Disease and Transplantation

Introduction: Liver chemistry abnormalities are a frequent manifestation of coronavirus disease 2019 (COVID-19) but are usually transient and resolve with disease resolution. Methods: We describe the clinical course and histologic features of 3 adults who developed prolonged and severe cholestasis during recovery from critical cardiopulmonary COVID-19. Results: These patients had clinical and histologic features similar to secondary sclerosing cholangitis of the critically ill patient, but with unique histologic features including severe cholangiocyte injury and intrahepatic microangiopathy suggestive of direct hepatic injury from COVID-19. DISCUSSION: We believe that these cases constitute a novel severe post–COVID-19 cholangiopathy with potential for long-term hepatic morbidity.